-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RCcqCEUtFJjINZsieRvdG5kOeQ2E6d7S332X3cLqNCDInKkC+pLit2FJLHQvvd7a aqao5YBMqRCgvQsW3QV+iA== 0000950153-06-002365.txt : 20060918 0000950153-06-002365.hdr.sgml : 20060918 20060918131802 ACCESSION NUMBER: 0000950153-06-002365 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060918 ITEM INFORMATION: Other Events FILED AS OF DATE: 20060918 DATE AS OF CHANGE: 20060918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORTHOLOGIC CORP CENTRAL INDEX KEY: 0000887151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860585310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21214 FILM NUMBER: 061095161 BUSINESS ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 6024375520 MAIL ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET CITY: TEMPE STATE: AZ ZIP: 85281 8-K 1 p72907e8vk.htm 8-K e8vk
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report: September 18, 2006
(Date of earliest event reported)
ORTHOLOGIC CORP.
 
(Exact name of registrant as specified in its charter)
         
Delaware   000-21214   86-0585310
         
(State or other jurisdiction of
incorporation) 		  (Commission File Number)   (I.R.S. Employer
Identification No.)
     
1275 West Washington Street, Tempe, Arizona   85281
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code:
(602) 286-5520
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 8.01 Other Events
Right to Put Shares to NovaQuest Not Exercised.
As previously reported on Forms 8-K filed March 3, 2006 and July 6, 2006, on February 27, 2006 OrthoLogic Corp. (the “Company”) entered into a Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) with PharmaBio Development Inc. (d/b/a NovaQuest) (“NovaQuest”), an affiliate of Quintiles Transnational Corp. and Quintiles, Inc., under which the Company subsequently issued an aggregate of 1,262,531 shares of its common stock, at an aggregate purchase price of $3,500,000, and warrants to purchase an aggregate of 404,129 shares of its common stock at various prices. Under the Purchase Agreement, the Company has the right to require NovaQuest to purchase an additional $1,500,000 of its common shares on September 30, 2006, at a purchase price based on a trailing average closing stock price. In connection with a purchase of shares the Company would have been required to issue common stock warrants in a specified amount. On September 14, 2006, the Company notified NovaQuest that it will not exercise this right. Accordingly, the Company has no further right to request NovaQuest purchase shares of its common stock and NovaQuest has no further obligation to purchase such shares under the Purchase Agreement.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Dated: September 18, 2006  ORTHOLOGIC CORP.
 		  
  /s/ Les M. Taeger    
  Les M. Taeger   
  Chief Financial Officer   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----